A targeted immunotherapy approach for HER2/neu transformed tumors by coupling an engineered effector domain with interferon-γ
Hongtao Zhang(Chinese Academy of Sciences), Mark I. Greene, Lian Lam(University of Pittsburgh), Yasuhiro Nagai(University of Pennsylvania), Mei Ji(The First People's Hospital of Changzhou), Zhiqiang Zhu(University of Pennsylvania), Xi Chen(Jilin Province Science and Technology Department)
Cited by 14
Related Papers
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435
Magnetically Propelled Fish‐Like Nanoswimmers
|Small|2016|271